These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 10388959

  • 1. Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study.
    Shalita AR, Chalker DK, Griffith RF, Herbert AA, Hickman JG, Maloney JM, Miller BH, Tschen EH, Chandraratna RA, Gibson JR, Lew-Kaya DA, Lue JC, Sefton J.
    Cutis; 1999 Jun; 63(6):349-54. PubMed ID: 10388959
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial.
    Webster GF, Berson D, Stein LF, Fivenson DP, Tanghetti EA, Ling M.
    Cutis; 2001 Jun; 67(6 Suppl):4-9. PubMed ID: 11499329
    [Abstract] [Full Text] [Related]

  • 3. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E, Dhawan S, Torok H, Kircik L.
    Dermatol Online J; 2007 Jul 13; 13(3):1. PubMed ID: 18328195
    [Abstract] [Full Text] [Related]

  • 4. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR, Berson DS, Thiboutot DM, Leyden JJ, Parizadeh D, Sefton J, Walker PS, Gibson JR, Tazarotene Cream in Acne Clinical Study Investigator Group.
    Clin Ther; 2004 Nov 13; 26(11):1865-73. PubMed ID: 15639698
    [Abstract] [Full Text] [Related]

  • 5. Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.
    Leyden J, Lowe N, Kakita L, Draelos Z.
    Cutis; 2001 Jun 13; 67(6 Suppl):10-6. PubMed ID: 11499327
    [Abstract] [Full Text] [Related]

  • 6. Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.
    Leyden JJ, Tanghetti EA, Miller B, Ung M, Berson D, Lee J.
    Cutis; 2002 Feb 13; 69(2 Suppl):12-9. PubMed ID: 12095064
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
    Thiboutot D, Arsonnaud S, Soto P.
    J Drugs Dermatol; 2008 Jun 13; 7(6 Suppl):s3-10. PubMed ID: 18575220
    [Abstract] [Full Text] [Related]

  • 8. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
    Webster GF, Guenther L, Poulin YP, Solomon BA, Loven K, Lee J.
    Cutis; 2002 Feb 13; 69(2 Suppl):4-11. PubMed ID: 12095066
    [Abstract] [Full Text] [Related]

  • 9. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
    Tanghetti E, Dhawan S, Green L, Ling M, Downie J, Germain MA, Kasteler JS, Kircik L, Oefelein MG, Draelos Z.
    J Drugs Dermatol; 2011 Jul 13; 10(7):783-92. PubMed ID: 21720661
    [Abstract] [Full Text] [Related]

  • 10. Randomized facial tolerability studies comparing gel formulations of retinoids used to treat acne vulgaris.
    Leyden J, Grove GL.
    Cutis; 2001 Jun 13; 67(6 Suppl):17-27. PubMed ID: 11499328
    [Abstract] [Full Text] [Related]

  • 11. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
    Gold LS, Colón LE, Johnson LA, Gottschalk RW.
    J Drugs Dermatol; 2008 Jun 13; 7(6 Suppl):s11-7. PubMed ID: 18575221
    [Abstract] [Full Text] [Related]

  • 12. The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies.
    Feldman SR, Werner CP, Alió Saenz AB.
    J Drugs Dermatol; 2013 Apr 13; 12(4):438-46. PubMed ID: 23652892
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of topical tazarotene in the treatment of mild to moderate acne.
    Leyden JJ.
    Cutis; 2004 Oct 13; 74(4 Suppl):9-15. PubMed ID: 15543714
    [Abstract] [Full Text] [Related]

  • 14. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R, Rizer R, Barba A, Wilson D, Stewart D, Grossman R, Nighland M, Weiss J.
    Clin Ther; 2007 Jun 13; 29(6):1086-97. PubMed ID: 17692723
    [Abstract] [Full Text] [Related]

  • 15. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
    Leyden J, Thiboutot DM, Shalita AR, Webster G, Washenik K, Strober BE, Shupack J.
    Arch Dermatol; 2006 May 13; 142(5):605-12. PubMed ID: 16702498
    [Abstract] [Full Text] [Related]

  • 16. Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
    Pariser D, Colón LE, Johnson LA, Gottschalk RW.
    J Drugs Dermatol; 2008 Jun 13; 7(6 Suppl):s18-23. PubMed ID: 18575222
    [Abstract] [Full Text] [Related]

  • 17. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris.
    Tanghetti EA, Kircik LH, Green LJ, Guenin E, Harris S, Martin G, Pillai R.
    J Drugs Dermatol; 2019 Jun 01; 18(6):542. PubMed ID: 31251546
    [Abstract] [Full Text] [Related]

  • 18. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.
    Leyden JJ, Shalita A, Thiboutot D, Washenik K, Webster G.
    Clin Ther; 2005 Feb 01; 27(2):216-24. PubMed ID: 15811485
    [Abstract] [Full Text] [Related]

  • 19. Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel.
    Bershad S, Kranjac Singer G, Parente JE, Tan MH, Sherer DW, Persaud AN, Lebwohl M.
    Arch Dermatol; 2002 Apr 01; 138(4):481-9. PubMed ID: 11939810
    [Abstract] [Full Text] [Related]

  • 20. Novel Polymeric Lotion Formulation of Once-Daily Tazarotene (0.045%) for Moderate-to-Severe Acne: Pooled Phase 3 Analysis.
    Tanghetti EA, Werschler WP, Lain E, Guenin E, Harris S, Loncaric A, Pillai R.
    J Drugs Dermatol; 2020 Mar 01; 19(3):272-279. PubMed ID: 32549090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.